Related Experiment Video

Updated: Jul 18, 2026

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

Genetic basis of respiratory distress syndrome

Mikko Hallman1, Ritva Haataja

  • 1Children's Hospital, Oulu University Central Hospital, and Biocenter Oulu, University of Oulu, Finland. mhallman@cc.oulu.fi

Frontiers in Bioscience : a Journal and Virtual Library
|November 28, 2006
PubMed

Insights

Genetic factors, including surfactant protein gene variants and prematurity, significantly influence the risk of respiratory distress syndrome (RDS). Understanding these genetic predispositions may lead to new therapies for this lung immaturity disease.

Area of Science:

  • Neonatal Medicine
  • Genetics
  • Pulmonology

Background:

  • Respiratory distress syndrome (RDS), or hyaline membrane disease, is a lung immaturity condition characterized by surfactant deficiency.
  • Alveolar surfactant levels naturally increase in newborns within the first week of life.

Purpose of the Study:

  • To explore the genetic factors contributing to RDS susceptibility.
  • To investigate the role of allelic variants in surfactant protein genes and other candidate genes.
  • To understand how genetic predisposition varies with gestational age.

Main Methods:

  • Analysis of allelic variants in surfactant protein genes (SP-A1, SP-A2, SP-B, SP-C).
  • Examination of gene-environment interactions and polymorphisms (e.g., SP-B Ile131Thr).
  • Consideration of candidate genes like ABCA3 and GPRA involved in lung function and disease.

Main Results:

  • Specific allelic variants in surfactant protein genes are associated with RDS risk.
  • SP-A haplotypes and SP-B polymorphisms interact with other factors to influence RDS.
  • Genetic susceptibility is linked to the degree of prematurity and lung development stage.

Conclusions:

  • Genetic variations in surfactant proteins and other lung-related genes are key factors in RDS development.
  • Prematurity and gene-environment interactions modulate RDS risk.
  • Further research into genetic factors may enable novel diagnostics and individualized RDS therapies.

More Related Videos

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)

Published on: April 7, 2021

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...